Showing results (1021-1030 of 1,271) with videos related to
Sort By:
Pageof 128
Psychopharmacology Bulletin|January 1, 1993
Vitamin E in tardive dyskinesia: time course of effect after placebo substitutionL A Adler, E Peselow, E Duncan, et al.Psychopharmacology Bulletin|January 1, 1993
Neuroanatomical differences in the rate of beta-adrenergic receptor adaptation after repeated treatment with imipramineG E Duncan, I A Paul, G R BreesePsychopharmacology Bulletin|October 8, 1999
Treatment of depression--newer pharmacotherapiesC D Mulrow, J W Williams, M Trivedi, et al.Psychopharmacology Bulletin|October 8, 1999
Olanzapine therapy in elderly patients with schizophreniaM Sajatovic, D Perez, D Brescan, et al.Psychopharmacology Bulletin|October 8, 1999
Evaluation of individual subjects in the analog classroom setting: I. Examples of graphical and statistical procedures for within-subject ranking of responses to different delivery patterns of methylphenidateJ M Swanson, S B Wigal, D Udrea, et al.Psychopharmacology Bulletin|January 9, 2019
Cariprazine Augmentation to Antidepressant Therapy in Major Depressive Disorder: Results of a Randomized, Double-Blind, Placebo-Controlled TrialWillie R Earley, Hua Guo, György Németh, et al.Psychopharmacology Bulletin|January 1, 1989
A comparison of nefazodone, imipramine, and placebo in patients with moderate to severe depressionJ P Feighner, R Pambakian, R C Fowler, et al.Psychopharmacology Bulletin|January 1, 1992
Self-injurious behavior in the developmentally disabled: pharmacologic treatmentO T Osman, E L LoschenPsychopharmacology Bulletin|January 1, 1992
The role of adenylate cyclase in neuropsychiatric diseaseJ B Thilo, P W BurnetPsychopharmacology Bulletin|December 11, 2002
Clinical significance of drug binding, protein binding, and binding displacement drug interactionsC Lindsay DeVanePageof 128